Correction to “MO Oxygen Therapy Prevents Doxorubicin‐Induced Cardiotoxicity”

Key Points

• The aim is to correct previously reported findings regarding the effects of oxygen therapy on doxorubicin-induced cardiotoxicity.
• Correction of previously published findings and data regarding oxygen therapy
• Review of molecular mechanisms related to cardiotoxicity
• Analysis of potential biomarkers for heart damage
• Clarification of how oxygen therapy can prevent cardiotoxic effects of doxorubicin
• Updated insights into the safety profile of doxorubicin with oxygen therapy